期刊文献+

紫杉醇自微乳释药系统的制备及评价 被引量:6

Preparation and Quality Evaluation of Paclitaxel Self-Microemulsifying Drug Delivery System
原文传递
导出
摘要 目的研制紫杉醇自微乳并进行质量评价。方法考察紫杉醇在不同油相、乳化剂和助乳化剂中的溶解度,再通过滴制法绘制伪三元相图,确定最优的Km值和处方,制备紫杉醇自微乳;并考察自微乳的外观、形态、粒径、载药量和稳定性。结果以聚氧乙烯蓖麻油EL35-卵磷脂/无水乙醇/中碳链甘油酯/水形成了均匀稳定的系统;紫杉醇自微乳为淡黄色澄明液体,稳定,平均粒径19.4 nm,呈Gauss分布,透射电镜下成圆球形,分布均匀。自微乳经0.9%的氯化钠注射液和5%的葡萄糖注射液稀释10及50倍后,外观、pH值、载药量、粒径均无明显变化。结论紫杉醇自微乳易于制备、质量稳定,为紫杉醇新型制剂的研发提供了科学依据。 OBJECTIVE To prepare paclitaxel self-microemulsifying drug delivery system(PTX-SMEDDS) and evaluate its quality. METHODS The equilibrium solubility of paclitaxel in different compositions of oil, emulsifiers and assistant emulsifiers was in- vestigated. The optimal Km was determined and PTX-SMEDDS was prepared by using the method of titration to establish the pseudo-ter- nary phase diagram. The appearance, morphology, size distribution, concentration and stability of PTX-SMEDDS were determined. RE- SULTS PTX-SMEDDS prepared with EL-35, lecithin and anhydrous ethanol at the ratio of 4 : 1 : 6, containing 6% DOC-Na and 7.5% of MCT,was a uniform and stable colloidal system displaying as a translucent diluted-yellow solution. PTX-SMEDDS under elec- tron microscopy consisted of small spherical drops with a mean diameter of 19.4 nm. The appearance, pH, concentration and particle size of SMEDDS were stable after it was diluted with sodium chloride injection and glucose injection by 10-fold or 50-fold ,respectively. CONCLUSION The PTX-SMEDDS is easy to prepare and its quality is stable, which provieds some information for the development of new paclitaxel formulations.
出处 《中国药学杂志》 CAS CSCD 北大核心 2014年第6期485-489,共5页 Chinese Pharmaceutical Journal
基金 国家自然科学基金资助项目(30500666) 清华大学-裕元基金(20240000548)
关键词 紫杉醇 自微乳释药系统 伪三元相图 制备 质量评价 paclitaxel self-microemulsifying drug delivery system pseudo-temary phase diagram preparation quality evaluation
  • 相关文献

参考文献2

二级参考文献33

  • 1陈寒梅,姚二东,邱国福,梁淑彩,李宗桃,胡先明.盐酸阿比朵尔微乳的制备及其质量评价[J].中国医院药学杂志,2006,26(4):397-400. 被引量:5
  • 2彭海龙,刘清飞,罗国安,王义明,李宝才.RP-HPLC/UV法测定Beagle犬血浆中氢氯噻嗪浓度及药动学研究[J].药物分析杂志,2006,26(7):938-941. 被引量:2
  • 3AK Singla, A Garg, D Aggarwal. Paclitaxel and its formulation [ J]. Int. J. Pharm,2002,235 : 179 - 192.
  • 4Mu L, Feng SS. Fabrication characterization and in vitro release of paclitaxel (Taxol) loadedly ( lactic - co - glycolic acid ) mi- crospheres prepared by spray drying technique with lipid/choles- terol emulsifiers [ J]. J Control Release ,2001,76:239 - 254.
  • 5M J Heslinga, E M Mastria, O Eniola - Adefeso. Fabrication of biodegradable spheroidal microparticles for drug delivery applica- tions [ J]. J Control Release ,2009,138 ( 3 ) :235 - 242.
  • 6Holvoet C, Vander H. Y, Lories G, et al. Preparation and evalua- tion of Paelitaxel - containing liposomes [ J ]. Phamarzie, 2007, 62:126 - 132.
  • 7Tije A J, Verweij J, Loos WJ, et al. Pharmacological effects of for- mulation vehicles: implications for cancer chemotherapy [ J ]. Clin Pharmacokinet ,2003,42 ( 7 ) :665 - 685.
  • 8FreibergS, Zhu Xiao - xin. Polymer microspheres for controlled drug release [ J ]. Int J Pharm,2004,282 (1 -2) :1 -18.
  • 9Jin C, Bai L, Wu H, et al. Paclitaxel - loaded poly ( D, L - lactide - co - glycolide) nanoparticles for radiotherapy in hypoxic hu- man tumor cells in vitro [ J ]. Cancer Biol Ther, 2008,7 ( 6 ) : 911 -916.
  • 10Bh.ardwaj V, Ankola DD, Gupta SC, et al. PLGA nanoparticles stabilized with cationic surfactant: safety studies and application in oral delivery of paclitaxel to treat chemical - induced breast cancer in rat [ J]. Pharm Res,2009,26 ( 11 ) :2495 - 2503.

共引文献6

同被引文献57

引证文献6

二级引证文献15

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部